In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Adaptive Biotechnologies Corp (NASDAQ: ADPT) closed at $7.84 in the last session, down -2.12% from day before closing price of $8.01. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 1.42 million shares were traded. ADPT stock price reached its highest trading level at $8.19 during the session, while it also had its lowest trading level at $7.66.
Ratios:
We take a closer look at ADPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.52. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.96.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when PISKEL KYLE sold 248 shares for $4.98 per share. The transaction valued at 1,235 led to the insider holds 154,330 shares of the business.
Taylor Stacy L sold 26,922 shares of ADPT for $121,079 on Aug 22 ’24. The SVP and General Counsel now owns 139,365 shares after completing the transaction at $4.50 per share. On Aug 22 ’24, another insider, STACY L TAYLOR, who serves as the Officer of the company, bought 26,922 shares for $4.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 1157019392 and an Enterprise Value of 1138020224. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.53 while its Price-to-Book (P/B) ratio in mrq is 5.17. Its current Enterprise Value per Revenue stands at 6.419 whereas that against EBITDA is -7.744.
Stock Price History:
The Beta on a monthly basis for ADPT is 1.55, which has changed by 1.0 over the last 52 weeks, in comparison to a change of 0.19995654 over the same period for the S&P500. Over the past 52 weeks, ADPT has reached a high of $8.33, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 15.63%, while the 200-Day Moving Average is calculated to be 61.36%.
Shares Statistics:
According to the various share statistics, ADPT traded on average about 1.39M shares per day over the past 3-months and 1133860 shares per day over the past 10 days. A total of 147.56M shares are outstanding, with a floating share count of 142.73M. Insiders hold about 3.28% of the company’s shares, while institutions hold 93.06% stake in the company. Shares short for ADPT as of 1736899200 were 8656445 with a Short Ratio of 6.23, compared to 1734048000 on 9030599. Therefore, it implies a Short% of Shares Outstanding of 8656445 and a Short% of Float of 7.53.
